Citrullinated GFAP (human, recombinant)

Citrullinated GFAP (human, recombinant) （订货以CAS编码或英文名称为准）

Application|ELISA||Application|Western Blot||Product Type|Proteins||Research Area|Cell Biology|Cytoskeleton & Motor Proteins||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease||Research Area|Neuroscience|Neurodegenerative Disorders|Multiple Sclerosis||Research Area|Neuroscience|Ophthalmology

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC56058

分子式：C24H21F2NO3

CAS号：1296129-15-1

分子量：409.43

储存条件：-80

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC56058-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC56058-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC56058-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC56058-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC56058-100µg	Medlife	EA		¥7471.00	登录后可见

中文名称：	依折麦布四氢吡喃杂质(SCH59566)
中文别名：	依折麦布四氢吡喃杂质;依折麦布四氢吡喃;依折麦布四氢吡喃杂质(SCH59566)
英文名称：	Citrullinated GFAP (human, recombinant)
英文别名：	Ezetimibe Tetrahydropyran Impurity;(2R,3R,6S)-N,6-bis(4-fluorophenyl)-2-(4-hydroxyphenyl)oxane-3-carboxamide
CAS号：	1296129-15-1
分子式：	C24H21F2NO3
分子量：	409.43
详细描述	Application\|ELISA\|\|Application\|Western Blot\|\|Product Type\|Proteins\|\|Research Area\|Cell Biology\|Cytoskeleton & Motor Proteins\|\|Research Area\|Immunology & Inflammation\|Autoimmunity\|\|Research Area\|Neuroscience\|Neurodegenerative Disorders\|Alzheimer’s Disease\|\|Research Area\|Neuroscience\|Neurodegenerative Disorders\|Multiple Sclerosis\|\|Research Area\|Neuroscience\|Ophthalmology

搜索质检报告(COA)

相关产品

(S)-3-((2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy (4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one

(S)-3-((2R,5S)-2-((S)-(4-(benzyloxy)phenyl)((4-fluorophenyl)amino)methyl)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

(5S)-ethyl 5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4- hydroxyphenyl)methyl)-5-hydroxypentanoate

(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one

4-((2R,6S)-6-(4-fluorophenyl)tetrahydro-2H-pyran-2-yl)phenol

(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxy-2-((E)-4-hydroxybenzylidene)pentanoyl)-4-phenyloxazolidin-2-one

(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one

(5S)-methyl 5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4- hydroxyphenyl)methyl)-5-hydroxypentanoate

(3R,4S)-1-(4-Fluorophenyl)-3-[(S)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one